Cargando…

Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria

Malaria caused by the Plasmodium parasites is a major public health concern in malaria-endemic regions with P. falciparum causing the most severe form of the disease. The use of antimalarial drugs for the management of the disease proves to be one of the best methods to manage the disease. Unfortuna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodoameda, Peter, Duah-Quashie, Nancy Odurowah, Quashie, Neils Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129956/ https://www.ncbi.nlm.nih.gov/pubmed/35620049 http://dx.doi.org/10.1155/2022/3492696

Ejemplares similares

Plasmodium falciparum genetic factors rather than host factors are likely to drive resistance to ACT in Ghana
por: Hodoameda, Peter, et al.
Publicado: (2020)

Plasmodium falciparum Malaria Parasites in Ghana Show Signatures of Balancing Selection at Artemisinin Resistance Predisposing Background Genes
por: Tandoh, Kwesi Z, et al.
Publicado: (2021)

Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana
por: Ahorhorlu, Samuel Yao, et al.
Publicado: (2023)

An improved and highly sensitive microfluorimetric method for assessing susceptibility of Plasmodium falciparum to antimalarial drugs in vitro
por: Quashie, Neils B, et al.
Publicado: (2006)

In vitro susceptibility profile of Plasmodium falciparum clinical isolates from Ghana to antimalarial drugs and polymorphisms in resistance markers
por: Zhao, Wei, et al.
Publicado: (2022)

Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005–2018
por: Abuaku, Benjamin, et al.
Publicado: (2021)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2023)

Transcriptome-module phenotype association study implicates extracellular vesicles biogenesis in Plasmodium falciparum artemisinin resistance
por: Tandoh, Kwesi Z., et al.
Publicado: (2022)

An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs
por: Dery, Victor, et al.
Publicado: (2015)

Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under 5 years in 3 ecological zones in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2012)

Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2012)

Prevalence of congenital malaria in high-risk Ghanaian newborns: a cross-sectional study
por: Enweronu-Laryea, Christabel C, et al.
Publicado: (2013)

Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia
por: Mbye, Haddijatou, et al.
Publicado: (2022)

Genetic diversity of Plasmodium falciparum isolates from uncomplicated malaria cases in Ghana over a decade
por: Duah, Nancy O., et al.
Publicado: (2016)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015–2017
por: Abuaku, Benjamin, et al.
Publicado: (2019)

Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2016)

World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria
por: Plowe, Christopher V, et al.
Publicado: (2007)

An unusual recurrence of pruritic creeping eruption after treatment of cutaneous larva migrans in an adult Ghanaian male: a case report with a brief review of literature
por: Quashie, Neils Ben, et al.
Publicado: (2015)

Novel pfk13 polymorphisms in Plasmodium falciparum population in Ghana
por: Matrevi, Sena Adzoa, et al.
Publicado: (2022)

Monitoring antimalarial drug-resistance markers in Somalia
por: Jalei, Abdifatah Abdullahi, et al.
Publicado: (2023)

In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon
por: Zatra, Rafika, et al.
Publicado: (2012)

Data on selected antimalarial drug resistance markers in Zambia
por: Sitali, Lungowe, et al.
Publicado: (2020)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia
por: Norahmad, Nor Azrina, et al.
Publicado: (2016)

Country-Wide Surveillance of Molecular Markers of Antimalarial Drug Resistance in Senegal by Use of Positive Malaria Rapid Diagnostic Tests
por: Ndiaye, Magatte, et al.
Publicado: (2017)

Amplification of GTP-cyclohydrolase 1 gene in Plasmodium falciparum isolates with the quadruple mutant of dihydrofolate reductase and dihydropteroate synthase genes in Ghana
por: Osei, Musah, et al.
Publicado: (2018)

Antimalarial drug resistance: An overview
por: Antony, Hiasindh Ashmi, et al.
Publicado: (2016)

The threat of antimalarial drug resistance
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016)

Ethics and Antimalarial Drug Resistance
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)

The molecular basis of antimalarial drug resistance in Plasmodium vivax
por: Buyon, Lucas E., et al.
Publicado: (2021)

Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy
por: Duah, Nancy O, et al.
Publicado: (2013)

Drug resistance genomics of the antimalarial drug artemisinin
por: Winzeler, Elizabeth A, et al.
Publicado: (2014)

Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020)

A database of antimalarial drug resistance
por: Sibley, Carol Hopkins, et al.
Publicado: (2006)

The global challenge of antimalarial drug resistance
por: Ringwald, Pascal, et al.
Publicado: (2012)

The genomic architecture of antimalarial drug resistance
por: Cowell, Annie N, et al.
Publicado: (2019)

Residual Antimalarials in Malaria Patients from Tanzania – Implications on Drug Efficacy Assessment and Spread of Parasite Resistance
por: Hodel, Eva Maria, et al.
Publicado: (2009)

Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
por: Smolarz, Beata, et al.
Publicado: (2021)

Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003–2015
por: Hemming-Schroeder, Elizabeth, et al.
Publicado: (2018)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_u5phsnu4kajpium0sjc1me4jpk